Global

Current Studies

All
Bleeding Disorders
Hereditary Angioedema
Immunoglobulins
Perioperative Bleeding
Pulmonary
Therapeutic Proteins


Condition Additional Trial Information

Primary Immune Deficiency (PID)

Safety and Tolerability of Higher Infusion Parameters of IgPro20 (Hizentra) in Subjects With Primary Immunodeficiency (PID)

> Learn More

Primary Immune Deficiency

Study of Immune Deficiency Patients Treated With Subcutaneous Immunoglobulin (IgPro20, Hizentra®) on Weekly and Biweekly Schedules

> Learn More

Page 1 of 1
Share
LinkedIn Twitter Facebook Google+